Coherus Oncology Inc — Balance Sheet (NASDAQ:CHRS) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 841.65 M679.33 M480.85 M629.6 M448.53 M258.34 M Total liabilities 560.67 M581.61 M618.26 M823.03 M580.52 M197.33 M Total equity 280.97 M97.73 M-137.42 M-193.43 M-131.99 M61.01 M Total liabilities & shareholders' equities 841.65 M679.33 M480.85 M629.6 M448.53 M258.34 M Total debt 377.95 M381.9 M226.77 M227.61 M228.23 M— Net debt -163.25 M-35.29 M35.09 M109.86 M102.24 M—

News

Coherus Oncology: Setting Up For Important Readouts In Mid-2026 (NASDAQ:CHRS)

Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates

Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?

Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?

Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?

Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift

Oppenheimer reiterates Coherus Biosciences stock rating at Outperform

Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript

Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates

Coherus BioSciences earnings matched, revenue fell short of estimates

Phathom Pharmaceuticals, Inc. (PHAT) Reports Q4 Loss, Beats Revenue Estimates

Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates